DOI: 10.1055/s-00032260

Digestive Disease Interventions

References

Loupakis F, Cremolini C, Salvatore L. et al.
FOLFOXIRI plus bevacizumab as first-line treatment in BRAF mutant metastatic colorectal cancer.

Eur J Cancer 2014;
50 (01) 57-63

Download Bibliographical Data

Access: